Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL467701 | 1.00 | ESR1 (0.48) | ESR1ESR2MEN1KMT2ACA9 | |
| SCHEMBL14626976 | 1.00 | ESR1 (0.48) | ESR1ESR2MEN1KMT2ACA9 | |
| SCHEMBL14298196 | 0.89 | CA9 (0.52) | MEN1KMT2ACA9LMNACYP3A4 | |
| SCHEMBL12360950 | 0.89 | CA9 (0.52) | MEN1KMT2ACA9LMNACYP3A4 | |
| SCHEMBL12260084 | 0.81 | FURIN (0.61) | ESR1ESR2MEN1KMT2ACA9 | |
| SCHEMBL13645704 | 0.81 | CA9 (0.47) | ESR1ESR2KMT2ACA9HSD17B1 | |
| SCHEMBL4364091 | 0.81 | FURIN (0.61) | ESR1ESR2MEN1KMT2ACA9 | |
| SCHEMBL12741076 | 0.79 | CA9 (0.56) | CA9LMNACYP3A4MAPTCYP1A2 | |
| SCHEMBL514858 | 0.79 | CA9 (0.56) | CA9LMNACYP3A4MAPTCYP1A2 | |
| SCHEMBL514859 | 0.79 | CA9 (0.56) | CA9LMNACYP3A4MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | SIRONAX LTD (KY) | 2026-03-19 | — | — | US | disclosed |
| EP-4590674-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd (KY) | 2025-07-30 | — | — | EP | disclosed |
| US-10286504-B2 | Synthesis of paracetamol (acetaminophen) from biomass-derived p-hydroxybenzamide | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-05-14 | — | — | US | disclosed |
| US-10014474-B2 | Composition for forming gate insulating film, organic thin film transistor, electronic paper, and display device | FUJIFILM CORPORATION (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9929348-B2 | Organic semiconductor composition comprising organic semiconductor material and polymer compound | FUJIFILM CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9929348-B2 | Organic semiconductor composition comprising organic semiconductor material and polymer compound | FUJIFILM CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9343594-B2 | Conductive composition, conductive member and production method thereof, touch panel, and solar cell | FUJIFILM CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9343594-B2 | Conductive composition, conductive member and production method thereof, touch panel, and solar cell | FUJIFILM CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-20160064674-A1 | ORGANIC SEMICONDUCTOR COMOSITION, ORGANIC THIN-FILM TRANSISTOR, ELECTRONIC PAPER, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20160064674-A1 | ORGANIC SEMICONDUCTOR COMOSITION, ORGANIC THIN-FILM TRANSISTOR, ELECTRONIC PAPER, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10014474-B2 | Composition for forming gate insulating film, organic thin film transistor, electronic paper, and display device | TEC, EPCAM, MIF | ESR1 2822/4885ESR2 4557/4885MEN1 970/4885 |
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | NAMPT, NNMT, SARM1 | ESR1 3208/4885ESR2 863/4885MEN1 2008/4885 |
| US-10286504-B2 | Synthesis of paracetamol (acetaminophen) from biomass-derived p-hydroxybenzamide | HPD, HMBS, NAT1 | ESR1 4147/4885ESR2 4190/4885MEN1 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.